Earnings
Treace Targets A $700 Million Market Expansion While Lower-Priced Products Weigh On Revenue
Management expects fourth-quarter growth as surgeons adopt a wider portfolio, with only incremental additions to the sales force.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
Management expects fourth-quarter growth as surgeons adopt a wider portfolio, with only incremental additions to the sales force.
SEC Filings
Record output supported a higher annual forecast, while cash generation funded debt reduction and share repurchases.
Earnings
Operating cash use fell 56% from the second quarter as Profound added a U.S. equipment distribution channel through Cook Medical.
SEC Filings
The higher outlook includes VitalConnect revenue, while litigation charges widened the quarterly loss.
Deals
The oil and gas producer raised its merger-benefit outlook and plans to use Eagle Ford sale proceeds for buybacks and debt repayment.
Earnings
Asset sales and distributions generated approximately US$1.4 billion this year, while lottery-services earnings weakened.
Earnings
Dental sales weakened across all three businesses, while Wellspect posted record quarterly sales and free cash flow fell to zero.
Earnings
The drug developer expects its $403.8 million in cash and investments to support operations beyond the second quarter of 2029.
Earnings
Senior housing led comparable-property income growth of 13.8%, while third-quarter reported earnings per share fell.
Deals
The accounts were already public; eligible Essential holders would receive 0.305 American Water shares for each share if the merger closes.
SEC Filings
Research costs rose as the company prepares trial readouts and an FDA application, with cash expected to fund operations through 2029.
SEC Filings
Adjusted margins widened, but a change in how Franklin Templeton counts commitments complicates comparisons of investment flows.